Foreign Manufacturing Cost-Savings Might Be Offset By Regulatory Due Diligence, FDA's Woodcock Cautions
This article was originally published in The Pink Sheet Daily
Executive Summary
Companies may have more work down the line dealing with regulatory authorities if they manufacture products in foreign countries not following an accepted regulatory structure.